Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Advanced Malignancies × sitravatinib × 30 days × Clear all

Phase

Status

Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Clear-cell metastatic renal cell carcinoma 1 Carcinoma, Renal Cell 1 Advanced Malignancies 1

Interventions

zanidatamab 1 tislelizumab 1 sitravatinib 1 pamiparib 1 lenvatinib 1 Temozolomide 1 Midazolam 1 HMPL-013 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04164199 2026-03-16

Study of Tislelizumab, Pamiparib, and Other Investigational Agents in Participants With Advanced Malignancies

BeOne Medicines

Phase 3 Enrolling by invitation

Advanced Malignancies

Data powered by HemOnc (CC BY 4.0) Colophon ⚡